Replimune (REPL) stock is in focus as the FDA agreed to have a third look at the company's lead drug for melanoma after White House intervention. Read more here.

Visa said that over 1,000 employees has been using Replit for prototyping and development ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Thanks to a new collaboration, Replit is giving people a simpler way to make money with their vibe-coded apps and websites.

Neal J. Riley is a digital producer for CBS Boston. He has been with WBZ-TV since 2014. His work has appeared in The Boston Globe and The San Francisco Chronicle. Neal is a graduate of Boston ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...